Common Contracts

STRICTLY PRIVATE AND CONFIDENTIAL

Private And • May 6th, 2020 • British Columbia

• Contract Type
  Private And
• Filed
  May 6th, 2020
• Jurisdiction
  British Columbia

This binding letter agreement sets out the agreement of the Parties (as defined below) with respect to, among other things, the granting to BetterLife Pharma Inc., or such designated subsidiary of BetterLife Pharma Inc. as the Parties mutually agree upon (“BLF”) of certain exclusive rights in and to intellectual property relating to the AP-003 Program of Altum Pharmaceuticals Inc. (“Altum”): Interferon α2b (“IFN α2b”) for the Treatment of Coronavirus Disease of 2019 (COVID-19) (the “AP-003 Program”) (the granting of such rights, the “Transaction”).